StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.90+0.14 (+3.72%)

Close on Nov 18, 2026Market cap $94.48MP/E –Yield –

Exagen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Exagen's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.50M. For fiscal 2025 it was -$13.63M. The highest annual figure on record is -$9.30M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.63M–
FY2024Dec 31, 2024-$13.28M–
FY2023Dec 31, 2023-$14.46M–
FY2022Dec 31, 2022-$32.14M–
FY2021Dec 31, 2021-$20.27M–
FY2020Dec 31, 2020-$14.08M–
FY2019Dec 31, 2019-$9.71M–
FY2018Dec 31, 2018-$9.30M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.99M–
Q1 FY2026Mar 31, 2026-$10.42M–
Q4 FY2025Dec 31, 2025-$3.01M-930.0%
Q3 FY2025Sep 30, 2025$2.94M–
Q2 FY2025Jun 30, 2025-$2.89M–
Q1 FY2025Mar 31, 2025-$10.67M–
Q4 FY2024Dec 31, 2024$363.00K-95.7%
Q3 FY2024Sep 30, 2024-$2.18M–
Q2 FY2024Jun 30, 2024-$2.43M–
Q1 FY2024Mar 31, 2024-$9.04M–
Q4 FY2023Dec 31, 2023$8.35M–
Q3 FY2023Sep 30, 2023-$2.91M–
Q2 FY2023Jun 30, 2023-$10.15M–
Q1 FY2023Mar 31, 2023-$9.75M–
Q4 FY2022Dec 31, 2022-$5.73M–
Q3 FY2022Sep 30, 2022-$6.68M–
Q2 FY2022Jun 30, 2022-$11.15M–
Q1 FY2022Mar 31, 2022-$8.57M–
Q4 FY2021Dec 31, 2021-$6.05M–
Q3 FY2021Sep 30, 2021-$5.46M–
Q2 FY2021Jun 30, 2021-$4.45M–
Q1 FY2021Mar 31, 2021-$4.31M–
Q4 FY2020Dec 31, 2020-$3.90M–
Q3 FY2020Sep 30, 2020-$2.13M–
Q2 FY2020Jun 30, 2020-$4.76M–
Q1 FY2020Mar 31, 2020-$3.30M–
Q4 FY2019Dec 31, 2019-$3.93M–
Q3 FY2019Sep 30, 2019-$1.67M–
Q2 FY2019Jun 30, 2019-$2.17M–
Q1 FY2019Mar 31, 2019-$1.95M–
Q4 FY2018Dec 31, 2018-$1.87M–

More Exagen figures

See a number that looks wrong?